SETD2 and nonpapillary renal cell carcinoma: A ccRCC mutation in the SET domain, R1625C, abolishes SETD2 catalytic activity, but the molecular basis for reduced methylation of tubulin by a ccRCC-associated mutation in the SRI domain (R2510H) remains unclear.